Overview

Tacrobell tab_Phase1_PK

Status:
Completed

Trial end date:
2015-03-19

Target enrollment:

Participant gender:

Summary

A randomized, open-label, two-way crossover study to assess the tolerability and pharmacokinetics of Tacrobell® Tab. and Prograf® Cap. after a single oral dose in healthy male volunteers.

Phase:

Phase 1

Details

Lead Sponsor:

Chong Kun Dang Pharmaceutical

Treatments:

Tacrolimus